These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

936 related articles for article (PubMed ID: 909598)

  • 61. Effects of l-dopa methyl ester on visual cortex injury induced by amblyopia and its underlying mechanism.
    Li R; Liang T; Li Y; Jiang W; Huang R
    Neurosci Lett; 2012 Feb; 508(2):95-100. PubMed ID: 22206838
    [TBL] [Abstract][Full Text] [Related]  

  • 62. L-dihydroxyphenylalanine methyl ester is a potent competitive antagonist of the L-dihydroxyphenylalanine-induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices.
    Goshima Y; Nakamura S; Misu Y
    J Pharmacol Exp Ther; 1991 Aug; 258(2):466-71. PubMed ID: 1865350
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A modified screening system to select new cytostatic drugs.
    Kraemer HP; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):301-28. PubMed ID: 6383326
    [No Abstract]   [Full Text] [Related]  

  • 64. Determination, purity assessment and chiral separation of levodopa methyl ester in bulk and formulation pharmaceuticals.
    Wang J; Fang Y
    Biomed Chromatogr; 2006 Sep; 20(9):904-10. PubMed ID: 16389643
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Isolation of antitumor polysaccharide fractions from Yucca glauca Nutt. (Lilliaceae).
    Ali MS; Sharma GC; Asplund RO; Nevins MP; Garb S
    Growth; 1978 Jun; 42(2):213-23. PubMed ID: 98392
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Trihexyphenidyl potentiation of L-DOPA: reduced effectiveness three years later in MPTP-induced chronic hemiparkinsonian monkeys.
    Domino EF; Ni L
    Exp Neurol; 1998 Aug; 152(2):238-42. PubMed ID: 9710523
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.
    Nestle FO; Alijagic S; Gilliet M; Sun Y; Grabbe S; Dummer R; Burg G; Schadendorf D
    Nat Med; 1998 Mar; 4(3):328-32. PubMed ID: 9500607
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immune stimulatory and anti-tumor properties of anti-CD3 and BAT monoclonal antibodies: a comparative study.
    Hardy B; Kovjazin R; Raiter A; Ganor N; Novogrodsky A
    Hum Antibodies; 1997; 8(2):95-8. PubMed ID: 9289394
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway].
    Jimbow K
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):105-10. PubMed ID: 9612704
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mortality of doctors in different specialties: findings from a cohort of 20000 NHS hospital consultants.
    Carpenter LM; Swerdlow AJ; Fear NT
    Occup Environ Med; 1997 Jun; 54(6):388-95. PubMed ID: 9245944
    [TBL] [Abstract][Full Text] [Related]  

  • 71. S-100 and NSE as serum markers in melanoma.
    Tofani A; Cioffi RP; Sciuto R; Rea S; Festa A; Di Filippo F; Cavaliere R; Maini CL
    Acta Oncol; 1997; 36(7):761-4. PubMed ID: 9490097
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cellular vaccine therapies for cancer.
    Mastrangelo MJ; Sato T; Lattime EC; Maguire HC; Berd D
    Cancer Treat Res; 1998; 94():35-50. PubMed ID: 9587681
    [No Abstract]   [Full Text] [Related]  

  • 73. Cardiac metastases from malignant melanoma.
    Gibbs P; Cebon JS; Calafiore P; Robinson WA
    Cancer; 1999 Jan; 85(1):78-84. PubMed ID: 9921977
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Therapeutic node dissections in malignant melanoma.
    Karakousis CP
    Ann Surg Oncol; 1998 Sep; 5(6):473-82. PubMed ID: 9754754
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differentiation of human fibroblasts to tissue macrophages by the Snyder-Theilen feline sarcoma virus (ST:FeSV): growth modulation of human tumor cell lines in agar.
    Wesseling B; Kopelovich L
    Anticancer Res; 1997; 17(4A):2599-602. PubMed ID: 9252687
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ultrastructural and immunohistochemical observations concerning laminin in B16 melanoma. Is an amorphous form of laminin promoting a non hematogenous migration of tumor cells?
    Lugassy C; Christensen L; Le Charpentier M; Faure E; Escande JP
    J Submicrosc Cytol Pathol; 1998 Jan; 30(1):137-44. PubMed ID: 9530861
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PET in oncology: will it replace the other modalities?
    Hoh CK; Schiepers C; Seltzer MA; Gambhir SS; Silverman DH; Czernin J; Maddahi J; Phelps ME
    Semin Nucl Med; 1997 Apr; 27(2):94-106. PubMed ID: 9144854
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The use of recombinant adeno-associated viral vectors for the transduction of epithelial tumor cells.
    Hoerer M; Bogedain C; Scheer U; Heberger C; Steyrer S; Burger A; Maass G
    Int J Immunopharmacol; 1997; 19(9-10):473-9. PubMed ID: 9637341
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines.
    Nakanishi O; Baba M; Saito A; Yamashita T; Sato W; Abe H; Fukazawa N; Suzuki T; Sato S; Naito M; Tsuruo T
    Oncol Res; 1997; 9(2):61-9. PubMed ID: 9167187
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds.
    Fargnoli MC; Chimenti S; Keller G; Soyer HP; Dal Pozzo V; Höfler H; Peris K
    J Invest Dermatol; 1998 Dec; 111(6):1202-6. PubMed ID: 9856841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.